Risks with Cytoreductive Therapy

Laura C. Michaelis, MD

Video Categories: Polycythemia Vera

Hear Dr. Michaelis discuss cytoreductive therapy and the risk factor for patients with hemorrhage.

Supported through funding from Incyte
July 29, 2015

Discussing Cost and Value with Patients

Dr. Steve O’Day understands that cost is a major concern for patients and urges oncologists to discuss the “big picture” with their patients so that they understand the full value of a treatment.

September 20, 2013

Personalized Medicine and the Affordable Care Act

Grant Lawless discusses the long term goal of personalized medicine as it relates to the Affordable Care Act